Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
LRVHealth
LRVHealth is a venture capital platform focused on the healthcare industry.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Gilde Healthcare
Gilde Healthcare is a European healthcare investor that specializes in lower mid-market buyouts and later stage venture.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
HealthQuest Capital
HealthQuest Capital is a private equity firm that invests in healthcare companies to optimize value, improve outcomes, and lower costs.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
Neo Kuma Ventures
Neo Kuma Ventures is a venture capital firm that invests in psychedelic healthcare companies.
Sector
Subsector
Location
count Of Investments
Financials
Investments4
Rani Therapeutics
Rani Therapeutics is a clinical-stage biotech company that has developed a robotic pill for the oral delivery of biologic drugs.
Sector
Subsector
Keywords
Location
total rounds
total raised
Rani Therapeutics
Rani Therapeutics is a clinical-stage biotech company that has developed a robotic pill for the oral delivery of biologic drugs.
Sector
Subsector
Keywords
Location
total rounds
total raised
Rani Therapeutics
Rani Therapeutics is a clinical-stage biotech company that has developed a robotic pill for the oral delivery of biologic drugs.
Sector
Subsector
Keywords
Location
total rounds
total raised
Co-Investors
People
Founders3
Andrew Farquharson
Andrew is an investor and entrepreneur with two decades of experience building, restructuring and acquiring companies in life sciences. A founding member of InCube's venture fund, Andrew is also an advisor to InCube Labs, LLC, which develops breakthrough medical technologies under the leadership of Mir Imran. Prior to joining InCube, Andrew served as a Partner in the Halo Funds, where he completed a Kauffman Fellowship and led investments in a portfolio of life science firms. These investments include Intrapace (obesity), Penumbra (ischemic stroke), Sonoma Orthopedic Products (bone repair), SwitchGear Genomics (gene regulation) & Spinal Modulation (pain management). Andrew has also been an active angel investor in a broader variety of ventures. Earlier in his career, Andrew served as Executive Vice President of sales, marketing and research for Operon Technologies. During his tenure there, Andrew built a global sales force from scratch, grew revenues of synthetic DNA products to $40M in two years, and helped to negotiate a sale of the business to QIAGEN for $150M. He subsequently acquired a company in Japan for QIAGEN, and restructured it into the company's global operations. Prior to Operon, Andrew held several roles in research operations at Genentech, Inc., where he managed $200M of protein therapeutic production and optimized cell lines for expression. Andrew has also co-founded a gene design business in agricultural biotechnology (Glucazyme), launched a company in microfludics (Innovadyne), sat on a wide range of boards, and developed strategies for healthcare firms as a consultant with Deloitte & Touche.
current job
Andrew Farquharson
Employee Profiles5
Andrew Farquharson
Managing Director and Co-Founder